The Danish Minister of Industry, Business and Financial Affairs said the investment signals 'a solid shift in the global quantum race'.

The announcement came amid a slump in the company's share price and investor concerns about its experimental drug pipeline ...

The company has looked internally for its new leader, as Doustdar is currently serving as its head of international ...

The collapse followed Novo's downward revision of its 2025 outlook, citing weaker-than-expected international uptake .

Novo Nordisk named Maziar Mike Doustdar as its new chief executive today, relying on an experienced company insider to revive sales and a share price hit by worries the maker of weight-loss drug ...

Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

In women with primary hyperparathyroidism, parathyroidectomy increases skeletal muscle strength and volume and triggers gene expression changes that resemble those seen after an exercise regimen.

Shares of Novo Nordisk skidded on Tuesday as the Danish drugmaker reduced its expectations on wildly popular drugs Ozempic ...

Danish pharma giant Novo Nordisk named Maziar Mike Doustdar as its new chief executive on Tuesday, relying on an experienced company insider to ...

Novo Nordisk (NYSE:NVO) has appointed Maziar Mike Doustdar as its new president and chief executive officer, effective August 7, 2025, the company announced on Tuesday.

Professor Lene Oddershede Chief Scientific Officer, Planetary Science & Technology at the Novo Nordisk Foundation talks about the applications of quantum computing at the tech disruptors podcast. She ...